Global Custom Market Research Reports Provider Company

phone

China Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • Published Date: 01 Aug 2017
  • Number of Pages: 120
  • Category: Healthcare and Medical
  • Country: China
China Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

GlobalDatas new report, "China Drug Delivery Devices Market Outlook to 2023", provides key market data on the China Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
- 2016 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the China Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.
Publisher Name : GlobalData

2 Introduction 7
2.1 What Is This Report About? 7
2.2 Drug Delivery Devices Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Drug Delivery Devices Market, China 11
3.1 Drug Delivery Devices Market, China, Revenue ($m), 2009-2023 11
3.2 Drug Delivery Devices Market, China, Revenue Mix ($m), 2016 13
3.3 Drug Delivery Devices Market, China, Category Contribution by Revenue ($m), 2016 14
3.4 Drug Delivery Devices Market, China, Category Comparison by Revenue ($m), 2009-2023 15
3.5 Drug Delivery Devices Market, China, Revenue ($m), 2009-2016 16
3.6 Drug Delivery Devices Market, China, Revenue ($m), 2016-2023 18
3.7 Drug Delivery Devices Market, China, Volume (Units), 2009-2023 20
3.8 Drug Delivery Devices Market, China, Volume (Units), 2009-2016 22
3.9 Drug Delivery Devices Market, China, Volume (Units), 2016-2023 24
3.10 Drug Delivery Devices Market, China, Company Share by Revenue ($m), 2016 26
4 Central Venous Catheters Market, China 28
4.1 Central Venous Catheters Market, China, Revenue Mix ($m), 2016 28
4.2 Central Venous Catheters Market, China, Segment Contribution (%), 2016 29
4.3 Central Venous Catheters Market, China, Revenue ($m), 2009-2016 30
4.4 Central Venous Catheters Market, China, Revenue ($m), 2016-2023 32
4.5 Central Venous Catheters Market, China, Volume (Units), 2009-2016 34
4.6 Central Venous Catheters Market, China, Volume (Units), 2016-2023 36
4.7 Central Venous Catheters Market, China, Distribution Share by Revenue ($m), 2015-2016 38
4.8 Central Venous Catheters Market, China, Company Share by Revenue ($m), 2016 39
5 Infusion Systems Market, China 41
5.1 Infusion Systems Market, China, Revenue Mix ($m), 2016 41
5.2 Infusion Systems Market, China, Segment Contribution (%), 2016 42
5.3 Infusion Systems Market, China, Revenue ($m), 2009-2016 43
5.4 Infusion Systems Market, China, Revenue ($m), 2016-2023 45
5.4.1 Ambulatory Infusion Pumps Market, China, Revenue ($m), by Segment, 2009-2016 47
5.4.2 Syringe Pumps Market, China, Revenue ($m), by Segment, 2009-2016 49
5.4.3 Ambulatory Infusion Pumps Market, China, Revenue ($m), by Segment, 2016-2023 51
5.4.4 Syringe Pumps Market, China, Revenue ($m), by Segment, 2016-2023 53
5.5 Infusion Systems Market, China, Volume (Units), 2009-2016 55
5.6 Infusion Systems Market, China, Volume (Units), 2016-2023 57
5.6.1 Ambulatory Infusion Pumps Market, China, Volume (Units), by Segment, 2009-2016 59
5.6.2 Syringe Pumps Market, China, Volume (Units), by Segment, 2009-2016 61
5.6.3 Ambulatory Infusion Pumps Market, China, Volume (Units), by Segment, 2016-2023 63
5.6.4 Syringe Pumps Market, China, Volume (Units), by Segment, 2016-2023 65
5.7 Infusion Systems Market, China, Distribution Share by Revenue ($m), 2015-2016 67
5.8 Infusion Systems Market, China, Company Share by Revenue ($m), 2016 68
6 Metered Dose Inhaler Devices Market, China 70
6.1 Metered Dose Inhaler Devices Market, China, Revenue ($m), 2009-2016 70
6.2 Metered Dose Inhaler Devices Market, China, Revenue ($m), 2016-2023 71
6.3 Metered Dose Inhaler Devices Market, China, Volume (Units), 2009-2016 72
6.4 Metered Dose Inhaler Devices Market, China, Volume (Units), 2016-2023 73
6.5 Metered Dose Inhaler Devices Market, China, Distribution Share by Revenue ($m), 2015-2016 74
6.6 Metered Dose Inhaler Devices Market, China, Company Share by Revenue ($m), 2016 75
7 Needle Free Injections Market, China 77
7.1 Needle Free Injections Market, China, Revenue ($m), 2009-2016 77
7.2 Needle Free Injections Market, China, Revenue ($m), 2016-2023 78
7.3 Needle Free Injections Market, China, Volume (Units), 2009-2016 79
7.4 Needle Free Injections Market, China, Volume (Units), 2016-2023 80
7.5 Needle Free Injections Market, China, Distribution Share by Revenue ($m), 2015-2016 81
7.6 Needle Free Injections Market, China, Company Share by Revenue ($m), 2016 82
8 Overview of Key Companies in China, Drug Delivery Devices Market 84
8.1 Teleflex Inc 84
8.1.1 Company Overview 84
8.2 GlaxoSmithKline Plc 84
8.2.1 Company Overview 84
8.3 AstraZeneca Plc 84
8.3.1 Company Overview 84
8.4 Boehringer Ingelheim GmbH 84
8.4.1 Company Overview 84
8.5 Fresenius Kabi AG 85
8.5.1 Company Overview 85
8.6 Pfizer Inc 85
8.6.1 Company Overview 85
8.7 Baxter International Inc 85
8.7.1 Company Overview 85
8.8 B. Braun Melsungen AG 86
8.8.1 Company Overview 86
8.9 Merck & Co Inc 86
8.9.1 Company Overview 86
8.10 Smiths Medical 86
8.10.1 Company Overview 86
8.11 Terumo Corp 86
8.11.1 Company Overview 86
8.12 Becton Dickinson and Co 87
8.12.1 Company Overview 87
8.13 Hospira Inc 87
8.13.1 Company Overview 87
8.14 Nipro Corp 87
8.14.1 Company Overview 87
8.15 Medtronic plc 87
8.15.1 Company Overview 87
9 Drug Delivery Devices Market Pipeline Products 88
10 Financial Deals Landscape 94
10.1 Asset Transactions 94
10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 94
10.2 Debt Offerings 96
10.2.1 Sichuan Kelun Pharma to Raise up to USD147.6 Million in Public Offering of Bonds Due 2020 96
10.2.2 Sichuan Kelun Pharma Raises USD58 Million in Public Offering of 4.89% Bonds Due 2022 97
10.2.3 Sichuan Kelun Pharma Raises USD72.7 Million in Public Offering of Bonds 98
10.2.4 Sichuan Kelun Pharma Plans to Raise up to USD269.5 Million in Public Offering of Bonds 99
10.3 Equity Offerings 100
10.3.1 Humanwell Healthcare Decreases Size of Private Placement of Shares for USD174 Million 100
10.3.2 Shandong Sito Bio-technology Raises USD155.6 Million in IPO of Shares 101
10.4 Partnerships 102
10.4.1 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 102
10.4.2 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 103
10.4.3 Pfizer Terminates its Licensing Agreement with pSivida 105
10.4.4 Bayer Enters into Licensing Agreement with DelSiTech 106
10.4.5 BioCorRx Enters into Licensing Agreement with Therakine 107
11 Recent Developments 108
11.1 Corporate Communications 108
11.1.1 Dec 07, 2016: MicroPort EP Attends Dunhuang Cardiovascular Disease Forum 108
11.1.2 Sep 01, 2016: First Firehawk Implantation in East Europe Completed 108
11.1.3 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 109
11.2 Financial Announcements 109
11.2.1 Mar 30, 2017: MPSC Announces 2016 Annual Results 109
11.2.2 Mar 24, 2017: LifeTech Announces 2016 Annual Results 111
11.2.3 Aug 30, 2016: MPSC Announces 2016 Interim Results 113
11.3 Product News 114
11.3.1 May 25, 2017: APR Applied Pharma Research at the 9th ChinaBio Partnering Forum: Bringing Swiss Made Innovations and Science Driven Technologies to Strengthen Its Presence in the Chinese Market 114
12 Appendix 116
12.1 Research Methodology 117
12.1.1 Coverage 117
12.1.2 Secondary Research 117
12.1.3 Primary Research 118
12.1.4 Company Share Analysis 118
12.1.5 Distribution Share Analysis 118
12.1.6 Benchmarking 119
12.2 GlobalData Consulting 119
12.3 Contact Us 120
12.4 Disclaimer 120

List Of Tables


Table 1: Drug Delivery Devices Market, China, Revenue ($m), USD Constant, 2009-2023 12
Table 2: Drug Delivery Devices Market, China, Category Contribution by Revenue ($m), 2016 14
Table 3: Drug Delivery Devices Market, China, Category Comparison by Revenue ($m), 2009-2023 15
Table 4: Drug Delivery Devices Market, China, Revenue ($m), USD Constant, Historic, 2009-2016 17
Table 5: Drug Delivery Devices Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023 19
Table 6: Drug Delivery Devices Market, China, Volume (Units), 2009-2023 21
Table 7: Drug Delivery Devices Market, China, Volume (Units), Historic, 2009-2016 23
Table 8: Drug Delivery Devices Market, China, Volume (Units), Forecast, 2016-2023 25
Table 9: Drug Delivery Devices Market, China, Company Share by Revenue ($m), USD Constant, 2016 27
Table 10: Central Venous Catheters Market, China, Segment Contribution (%), 2016 29
Table 11: Central Venous Catheters Market, China, Revenue ($m), USD Constant, Historic, 2009-2016 31
Table 12: Central Venous Catheters Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023 33
Table 13: Central Venous Catheters Market, China, Volume (Units), Historic, 2009-2016 35
Table 14: Central Venous Catheters Market, China, Volume (Units), Forecast, 2016-2023 37
Table 15: Central Venous Catheters Market, China, Distribution Share by Revenue ($m), USD Constant, 2015-2016 38
Table 16: Central Venous Catheters Market, China, Company Share by Revenue ($m), USD Constant, 2016 40
Table 17: Infusion Systems Market, China, Segment Contribution (%), 2016 42
Table 18: Infusion Systems Market, China, Revenue ($m), USD Constant, Historic, 2009-2016 44
Table 19: Infusion Systems Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023 46
Table 20: Ambulatory Infusion Pumps Market, China, Revenue ($m), USD Constant, Historic, 2009-2016 48
Table 21: Syringe Pumps Market, China, Revenue ($m), USD Constant, Historic, 2009-2016 50
Table 22: Ambulatory Infusion Pumps Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023 52
Table 23: Syringe Pumps Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023 54
Table 24: Infusion Systems Market, China, Volume (Units), Historic, 2009-2016 56
Table 25: Infusion Systems Market, China, Volume (Units), Forecast, 2016-2023 58
Table 26: Ambulatory Infusion Pumps Market, China, Volume (Units), Historic, 2009-2016 60
Table 27: Syringe Pumps Market, China, Volume (Units), Historic, 2009-2016 62
Table 28: Ambulatory Infusion Pumps Market, China, Volume (Units), Forecast, 2016-2023 64
Table 29: Syringe Pumps Market, China, Volume (Units), Forecast, 2016-2023 66
Table 30: Infusion Systems Market, China, Distribution Share by Revenue ($m), USD Constant, 2015-2016 67
Table 31: Infusion Systems Market, China, Company Share by Revenue ($m), USD Constant, 2016 69
Table 32: Metered Dose Inhaler Devices Market, China, Revenue ($m), USD Constant, Historic, 2009-2016 70
Table 33: Metered Dose Inhaler Devices Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023 71
Table 34: Metered Dose Inhaler Devices Market, China, Volume (Units), Historic, 2009-2016 72
Table 35: Metered Dose Inhaler Devices Market, China, Volume (Units), Forecast, 2016-2023 73
Table 36: Metered Dose Inhaler Devices Market, China, Distribution Share by Revenue ($m), USD Constant, 2015-2016 74
Table 37: Metered Dose Inhaler Devices Market, China, Company Share by Revenue ($m), USD Constant, 2016 76
Table 38: Needle Free Injections Market, China, Revenue ($m), USD Constant, Historic, 2009-2016 77
Table 39: Needle Free Injections Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023 78
Table 40: Needle Free Injections Market, China, Volume (Units), Historic, 2009-2016 79
Table 41: Needle Free Injections Market, China, Volume (Units), Forecast, 2016-2023 80
Table 42: Needle Free Injections Market, China, Distribution Share by Revenue ($m), USD Constant, 2015-2016 81
Table 43: Needle Free Injections Market, China, Company Share by Revenue ($m), USD Constant, 2016 83
Table 44: Drug Delivery Devices Market Pipeline Products 88
Table 45: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 94
Table 46: Sichuan Kelun Pharma to Raise up to USD147.6 Million in Public Offering of Bonds Due 2020 96
Table 47: Sichuan Kelun Pharma Raises USD58 Million in Public Offering of 4.89% Bonds Due 2022 97
Table 48: Sichuan Kelun Pharma Raises USD72.7 Million in Public Offering of Bonds 98
Table 49: Sichuan Kelun Pharma Plans to Raise up to USD269.5 Million in Public Offering of Bonds 99
Table 50: Humanwell Healthcare Decreases Size of Private Placement of Shares for USD174 Million 100
Table 51: Shandong Sito Bio-technology Raises USD155.6 Million in IPO of Shares 101
Table 52: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 102
Table 53: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 103
Table 54: Pfizer Terminates its Licensing Agreement with pSivida 105
Table 55: Bayer Enters into Licensing Agreement with DelSiTech 106
Table 56: BioCorRx Enters into Licensing Agreement with Therakine 107

List Of Figures


Figure 1: Drug Delivery Devices Market, China, Revenue ($m), USD Constant, 2009-2023 11
Figure 2: Drug Delivery Devices Market, China, Revenue Mix ($m), 2016 13
Figure 3: Drug Delivery Devices Market, China, Category Contribution (%), 2016 14
Figure 4: Drug Delivery Devices Market, China, Category Comparison by Revenue ($m), 2009-2023 15
Figure 5: Drug Delivery Devices Market, China, Revenue ($m), USD Constant, Historic, 2009-2016 16
Figure 6: Drug Delivery Devices Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023 18
Figure 7: Drug Delivery Devices Market, China, Volume (Units), 2009-2023 20
Figure 8: Drug Delivery Devices Market, China, Volume (Units), Historic, 2009-2016 22
Figure 9: Drug Delivery Devices Market, China, Volume (Units), Forecast, 2016-2023 24
Figure 10: Drug Delivery Devices Market, China, Company Share (%) 2016 26
Figure 11: Central Venous Catheters Market, China, Revenue Mix ($m), 2016 28
Figure 12: Central Venous Catheters Market, China, Segment Contribution (%), 2016 29
Figure 13: Central Venous Catheters Market, China, Revenue ($m), USD Constant, Historic, 2009-2016 30
Figure 14: Central Venous Catheters Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023 32
Figure 15: Central Venous Catheters Market, China, Volume (Units), Historic, 2009-2016 34
Figure 16: Central Venous Catheters Market, China, Volume (Units), Forecast, 2016-2023 36
Figure 17: Central Venous Catheters Market, China, Company Share (%) 2016 39
Figure 18: Infusion Systems Market, China, Revenue Mix ($m), 2016 41
Figure 19: Infusion Systems Market, China, Segment Contribution (%), 2016 42
Figure 20: Infusion Systems Market, China, Revenue ($m), USD Constant, Historic, 2009-2016 43
Figure 21: Infusion Systems Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023 45
Figure 22: Ambulatory Infusion Pumps Market, China, Revenue ($m), USD Constant, Historic, 2009-2016 47
Figure 23: Syringe Pumps Market, China, Revenue ($m), USD Constant, Historic, 2009-2016 49
Figure 24: Ambulatory Infusion Pumps Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023 51
Figure 25: Syringe Pumps Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023 53
Figure 26: Infusion Systems Market, China, Volume (Units), Historic, 2009-2016 55
Figure 27: Infusion Systems Market, China, Volume (Units), Forecast, 2016-2023 57
Figure 28: Ambulatory Infusion Pumps Market, China, Volume (Units), Historic, 2009-2016 59
Figure 29: Syringe Pumps Market, China, Volume (Units), Historic, 2009-2016 61
Figure 30: Ambulatory Infusion Pumps Market, China, Volume (Units), Forecast, 2016-2023 63
Figure 31: Syringe Pumps Market, China, Volume (Units), Forecast, 2016-2023 65
Figure 32: Infusion Systems Market, China, Company Share (%) 2016 68
Figure 33: Metered Dose Inhaler Devices Market, China, Revenue ($m), USD Constant, Historic, 2009-2016 70
Figure 34: Metered Dose Inhaler Devices Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023 71
Figure 35: Metered Dose Inhaler Devices Market, China, Volume (Units), Historic, 2009-2016 72
Figure 36: Metered Dose Inhaler Devices Market, China, Volume (Units), Forecast, 2016-2023 73
Figure 37: Metered Dose Inhaler Devices Market, China, Company Share (%) 2016 75
Figure 38: Needle Free Injections Market, China, Revenue ($m), USD Constant, Historic, 2009-2016 77
Figure 39: Needle Free Injections Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023 78
Figure 40: Needle Free Injections Market, China, Volume (Units), Historic, 2009-2016 79
Figure 41: Needle Free Injections Market, China, Volume (Units), Forecast, 2016-2023 80
Figure 42: Needle Free Injections Market, China, Company Share (%) 2016 82

The Vacuum Evaporation Boat revenue was 21.67 M $ in 2016 and is expected to reach 24.69 M $ in 2022, growing at a CAGR of 2.2% from 2016 to

View Report

Fabchem China Ltd (Fabchem) is a chemical company that manufactures and markets commercial explosives. The company offers products such as explosive devices, industrial fuse and initiating explosive devices, and industrial

View Report

China Bio Cassava Holdings Ltd (CBC), formerly Bio Cassava Technology Holdings Ltd is a provider of character inputting systems. The company offers matrix mapping system, Q9 CIS and Qcode Chinese

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports